Next Article in Journal
The Anti-Vascular Endothelial Growth Factor Receptor 1 (VEGFR-1) D16F7 Monoclonal Antibody Inhibits Melanoma Adhesion to Soluble VEGFR-1 and Tissue Invasion in Response to Placenta Growth Factor
Next Article in Special Issue
The Risk of Multiple Myeloma Is Reduced in Metformin Initiators: A Retrospective Cohort Study in Taiwanese Patients with Type 2 Diabetes Mellitus
Previous Article in Journal
The Role of the Aryl Hydrocarbon Receptor (AhR) and Its Ligands in Breast Cancer
Previous Article in Special Issue
The Dynamics of Nucleotide Variants in the Progression from Low–Intermediate Myeloma Precursor Conditions to Multiple Myeloma: Studying Serial Samples with a Targeted Sequencing Approach
 
 
Review

Article Versions Notes

Cancers 2022, 14(22), 5575; https://doi.org/10.3390/cancers14225575
Action Date Notes Link
article xml file uploaded 14 November 2022 10:15 CET Original file -
article xml uploaded. 14 November 2022 10:15 CET Update -
article pdf uploaded. 14 November 2022 10:15 CET Version of Record https://www.mdpi.com/2072-6694/14/22/5575/pdf-vor
article html file updated 14 November 2022 10:17 CET Original file -
article xml file uploaded 21 November 2022 03:00 CET Update -
article xml uploaded. 21 November 2022 03:00 CET Update -
article pdf uploaded. 21 November 2022 03:00 CET Updated version of record https://www.mdpi.com/2072-6694/14/22/5575/pdf-vor
article html file updated 21 November 2022 03:01 CET Update -
article xml file uploaded 21 November 2022 03:07 CET Update -
article xml uploaded. 21 November 2022 03:07 CET Update https://www.mdpi.com/2072-6694/14/22/5575/xml
article pdf uploaded. 21 November 2022 03:07 CET Updated version of record https://www.mdpi.com/2072-6694/14/22/5575/pdf
article html file updated 21 November 2022 03:08 CET Update -
article html file updated 28 February 2023 22:54 CET Update -
article html file updated 2 March 2023 23:11 CET Update https://www.mdpi.com/2072-6694/14/22/5575/html
Back to TopTop